These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18319565)

  • 1. Direct inhibition of N-methyl-D-aspartate (NMDA)-receptor function by antiglaucomatous beta-antagonists.
    Nagata T; Ueno S; Morita H; Kubota T; Toyohira Y; Tsutsui M; Tawara A; Yanagihara N
    J Pharmacol Sci; 2008 Mar; 106(3):423-34. PubMed ID: 18319565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels.
    Melena J; Stanton D; Osborne NN
    Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(7):522-30. PubMed ID: 11521697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
    Baptiste DC; Hartwick AT; Jollimore CA; Baldridge WH; Chauhan BC; Tremblay F; Kelly ME
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2666-76. PubMed ID: 12147601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
    Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
    Blondin C; Hamard P; Cholley B; Haeffner-Cavaillon N; Baudouin C
    Curr Eye Res; 2003 Oct; 27(4):253-9. PubMed ID: 14562177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery.
    Dong Y; Ishikawa H; Wu Y; Shimizu K; Goseki T; Yoshitomi T
    Jpn J Ophthalmol; 2006; 50(6):504-508. PubMed ID: 17180523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of beta antagonists on mechanical properties in rabbit ciliary artery.
    Hayashi-Morimoto R; Yoshitomi T; Ishikawa H; Hayashi E; Sato Y
    Graefes Arch Clin Exp Ophthalmol; 1999 Aug; 237(8):661-7. PubMed ID: 10459616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).
    Sun L; Chiu D; Kowal D; Simon R; Smeyne M; Zukin RS; Olney J; Baudy R; Lin S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):563-70. PubMed ID: 15075380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol.
    Wood JP; Schmidt KG; Melena J; Chidlow G; Allmeier H; Osborne NN
    Exp Eye Res; 2003 Apr; 76(4):505-16. PubMed ID: 12634114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
    Wu KY; Hong SJ; Wang HZ
    J Ocul Pharmacol Ther; 1997 Feb; 13(1):13-21. PubMed ID: 9029436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
    Buller AL; Monaghan DT
    Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
    Kloda A; Clements JD; Lewis RJ; Adams DJ
    Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of amino acid neurochemistry secondary to NMDA or betaxolol application.
    Sun D; Kalloniatis M
    Clin Exp Ophthalmol; 2004 Oct; 32(5):505-17. PubMed ID: 15498063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
    Chidlow G; Melena J; Osborne NN
    Br J Pharmacol; 2000 Jun; 130(4):759-66. PubMed ID: 10864881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.